Flex Pharma: 2Q Earnings Snapshot

August 1, 2018

BOSTON (AP) _ Flex Pharma Inc. (FLKS) on Wednesday reported a loss of $9.1 million in its second quarter.

The Boston-based company said it had a loss of 50 cents per share.

The biotech drug developer posted revenue of $246,000 in the period.

The company’s shares closed at 83 cents. A year ago, they were trading at $4.25.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLKS at https://www.zacks.com/ap/FLKS

Update hourly